TABER, ALBERTA, July 16, 2025 (GLOBE NEWSWIRE) -- FLEXIBLE SOLUTIONS INTERNATIONAL, INC. (NYSE-AMERICAN: FSI), is the developer and manufacturer of biodegradable polymers for oil extraction, detergent ingredients and water treatment as well as crop nutrient availability chemistry. Flexible Solutions also manufactures biodegradable and environmentally safe water and energy conservation technologies. In addition, FSI is increasing its presense in the food and nutrition supplement manufacturing markets. Today the Company announces second quarter (Q2), 2025 revenue.
Discover how CrazyBulk’s natural legal steroids are transforming muscle building supplements for bodybuilding women seeking safe, effective female muscle growth.
Discover how CrazyBulk’s natural legal steroids are transforming muscle building supplements for bodybuilding women seeking safe, effective female muscle growth.
The video service subscription economy generates $106 billion in revenue annually
DALLAS, July 16, 2025 /PRNewswire/ -- International research and consulting firm Parks Associates today announced...
HONG KONG, July 16, 2025 /PRNewswire/ -- To promote K-Food Korean ginseng, the aT Center Hong Kong (Korea Agro-Fisheries & Food Trade Corporation Hong Kong Branch) joined...
NEW YORK, July 15, 2025 /PRNewswire/ -- Fly-E Group, Inc. (Nasdaq: FLYE) ("Fly-E" or the "Company"), an electric vehicle company engaged in designing, installing,...
BETHESDA, Md., July 15, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase common stock in an underwritten public offering. Gain expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock and/or the warrants offered in the offering. All of the securities are being offered by the Company.
Albany, New York, July 15, 2025 (GLOBE NEWSWIRE) -- In the ever-evolving world of fitness and bodybuilding, achieving optimal muscle growth, fat loss, and recovery without compromising health is paramount. Selective Androgen Receptor Modulators (SARMs) have emerged as a promising alternative to traditional anabolic steroids, offering similar benefits with reduced side effects. However, the safety and legality of SARMs vary, making it crucial for enthusiasts to exercise caution when choosing wisely.
/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
Base Shelf Prospectus Accessible and Prospectus Supplement to be...
TSXV: ESBL
VANCOUVER, BC, July 15, 2025 /PRNewswire/ - Eshbal Functional Food Inc. (TSXV: ESBL) ("Eshbal" or the "Company"), a developer of gluten-free and health-focused...
CWV: TSX.V
CALGARY, AB, July 14, 2025 /CNW/ - (TSXV: CWV) : Crown Point Energy Inc. ("Crown Point", the "Company" or "we") is pleased to announce that on July 11, 2025, its...